Aerovate Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
AVTE
CUSIP
008064107
Type
Equity
Class
COM
Num filings
19
Total reported value, excl. options
$454 M
Manager Report Date Value ($000) Shares Option Type